mutation
A scientist’s opinion : Interview with Prof. András Falus about SARS-CoV-2 mutations
András Falus was born in 1947 in Budapest, Hungary and is a professor emeritus of Budapest’s Semmelweis University and a member of the Hungarian Academy of Sciences. His primary field of study is immunogenomics, allergy and onco-genomics. Most recently, his research has focused on histamine-related immunoregulation, non-coding DNA (e.g. microRNA) and microvesicles, a newly recognised ...
A scientist’s opinion: Interview with Dr Deepti Gurdasani about SARS-CoV-2 mutations
Dr Deepti Gurdasani ’s background is as a clinical epidemiologist and statistical geneticist. After completing her clinical training in internal medicine at Christian Medical College, Vellore, India, she completed her MPhil in epidemiology and biostatistics at the University of Cambridge in 2010, followed by a PhD examining genetic factors associated with disease in genetically diverse ...
SARS-CoV-2: the challenges of mutation and possible strategies
The efficacy of the current COVID-19 vaccines might be lower against the new variants of SARS-CoV-2. The new strain that emerged in the United Kingdom has a higher transmissibility than previous strains of the virus. We asked scientists whether the new mutations are a threat to the current public health measures and to COVID-19 vaccines.
